Herold Advisors, Inc. Abb Vie Inc. Transaction History

Herold Advisors, Inc.

$449 Million
Q3 2024

A detailed history of Herold Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Herold Advisors, Inc. holds 38,744 shares of ABBV stock, worth $6.97 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares

38,744

Previous 39,149 1.03%

Holding current value

$6.97 Million

Previous $6.71 Million 13.96%

% of portfolio

1.7%

Previous 1.59%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $66,355 - $80,728	-405 Reduced 1.03%	38,744 $7.65 Million
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $124,451 - $145,331	804 Added 2.1%	39,149 $6.71 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $69,202 - $78,849	-433 Reduced 1.12%	38,345 $6.98 Million
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $93,843 - $105,689	682 Added 1.79%	38,778 $6.01 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $343,059 - $397,141	2,568 Added 7.23%	38,096 $5.68 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $206,450 - $256,914	1,558 Added 4.59%	35,528 $4.79 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $5,495 - $6,328	38 Added 0.11%	33,970 $5.41 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $212,167 - $254,444	1,534 Added 4.73%	33,932 $5.49 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $38,786 - $44,485	289 Added 0.9%	32,398 $4.35 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $36,331 - $46,189	264 Added 0.83%	32,109 $4.92 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $154,812 - $192,078	1,173 Added 3.82%	31,845 $5.16 Million
Q4 2021 Jan 20, 2022	SELL	$107.43 - $135.93 $15,147 - $19,166	-141 Reduced 0.46%	30,672 $4.15 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $3.28 Million - $3.72 Million	30,813 New	30,813 $3.32 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.

Account

Herold Advisors, Inc. Abb Vie Inc. Transaction History